Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rare Earth Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel rare earth silamide catalyzed one-pot synthesis for high-purity spiro[cyclopropane-1,3'-indole] intermediates. Cost-effective and scalable pharma manufacturing.
Patent CN108250236B reveals a novel ytterbium catalyst for efficient, solvent-free synthesis of alpha-hydroxy phosphates, offering significant cost and supply chain advantages.
Patent CN110028407B details a novel rare earth catalyzed one-pot synthesis for spiro cyclopropane indene diketones, offering high stereoselectivity and cost-effective manufacturing for global supply chains.
Patent CN112939994B details a novel low-loading lanthanum catalyzed method for synthesizing pyrano[2,3-b]indol-2-one scaffolds, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN110590679A enables mild rare earth catalysis for barbituric acid derivatives, offering cost reduction in pharma manufacturing and reliable supply chain continuity.
Patent CN105646231B introduces a green alcoholysis method for 2,4-dichloro-5-nitrophenol, offering higher purity and reduced waste for oxadiazon manufacturing supply chains.
Patent CN108715574B reveals a green Sm-Cu catalyzed route for 4,4'-biphenol. Achieve high purity and cost reduction in fine chemical manufacturing with recyclable ionic liquids.
Patent CN110028407A reveals a rare earth catalyzed method for spiro[cyclopropane-1,2'-indene]-1',3'-dione synthesis offering high stereoselectivity and supply chain advantages.
Patent CN108164555B reveals a high-efficiency rare earth catalyst for boronic ester synthesis, offering mild conditions and significant cost reduction in fine chemical manufacturing.
Patent CN105669747B reveals a novel ytterbium catalyst for α-hydroxy phosphate synthesis, offering mild conditions and significant supply chain cost advantages.
Novel rare earth catalyzed synthesis offers high yield and mild conditions for aminoisoindole derivatives, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel rare earth catalyzed method for aromatic formamide and olefin. Offers mild conditions and high purity for pharmaceutical intermediates manufacturing.
Novel rare earth catalyzed decarbonylation hydroamination process offers mild conditions and high purity for pharmaceutical intermediate manufacturing supply chain optimization.
Patent CN103613551A details a novel rare earth-catalyzed route for 1,5-disubstituted-1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN117069602B reveals a cleaner rare earth catalytic route for gamma-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel anti-Markovnikov hydroamination method using rare earth catalysts offers high purity pharmaceutical intermediates with reduced environmental impact and simplified supply chains.
Innovative rare earth metal cluster catalysis enables solvent-free amide synthesis with high yields and broad substrate scope enhancing supply chain reliability for pharmaceutical intermediates
Rare earth-catalyzed hydroamination method achieves high-yield gamma-amino alcohol synthesis with simplified process and reduced environmental impact for pharmaceutical manufacturing.
Overcome low yields & noble metal costs in dibenzoazepine synthesis. NINGBO INNO PHARMCHEM delivers 85%+ yield, 99% purity, and GMP-compliant scale-up for pharma R&D.
Solve sesamin precursor synthesis challenges with this rare earth metal method. 60-90% yield, air-stable operation, and reduced supply chain risks for pharma R&D and production.